What AI says about FidoCure

FidoCure uses genomic testing and tumor profiling to identify cancer-driving mutations in dogs, enabling personalized therapeutic recommendations beyond standard chemo and radiation. The company has developed the largest proprietary canine cancer data set in the world, with published research demonstrating that its precision medicine approach can decrease the risk of death from certain cancers by up to half.